Darrin Disley Overview

  • Investor Type
  • Angel
  • Status
  • Active
  • Professionals
  • 1
Professionals
  • Investments
  • 6
  • Portfolio
  • 3
  • Exits
  • 2
Exits

Darrin Disley General Information

Description

Dr. Darrin Disley serves as Co-Chief Executive Officer at Horizon Genomics. He Co-Founded & served as Board Member at GeoSpock. He serves as Chairman at Celixir. He also served as President, Chief Executive Officer & Board Member at Horizon Discovery. Darrin is a successful serial entrepreneur who has been involved in the start-up and growth of a number of business ventures. Since joining in 2007, he has been instrumental in growing Horizon from a small start-up in Cambridge in the UK into a rapidly growing multinational leader in the life sciences. During this time, Darrin has built a world-class management team, set the commercial and business strategy, led the company through multiple financing rounds including the Company's highly successful IPO in 2014, and driven the acquisitions of CombinatoRx, Sage Labs, Haplogen Genomics and Avvinity Therapeutics. Darrin is the holder of multiple business awards including Scrip Executive of the Year in 2014, a global award recognising leadership in biotechnology and pharmaceutical companies, UK quoted company entrepreneur of the Year in 2015, and was recently conferred with a lifetime held Queens Award for Enterprise Promotion by Her Majesty Queen Elizabeth the II in recognition of his contribution to Life Science entrepreneurship. He is a strong supporter of numerous academic, entrepreneurship and mentoring programs across the UK. Darrin also sits on the Boards of several companies and organizations including Cell Therapy Ltd, Desktop Genetics Ltd and the UK Bioindustry Association, and is an Angel investor in over 30 UK companies in the technology and life science sectors. He holds a PhD in Biotechnology from the University of Cambridge. He also serves as an Advisor, Life Sciences at Bailey Fisher Executive Search.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Cambridge
  • England, United Kingdom

Darrin Disley Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bit Bio 16-Nov-2017 Seed Round 00000 Biotechnology Generating Revenue 000000 000000 00.0
00000000000 02-Jun-2016 0000 00000 00000 Information Services (B2C) Out of Business 000000 000000 00.0
0000 00000000000 24-Mar-2016 000000 00000 00.000 Biotechnology Profitable 000000 000000 00.0
00000000 07-Oct-2015 00000 00000 00.000 Database Software Generating Revenue 000000 000000 00.0
Desktop Genetics 15-Sep-2015 Early Stage VC 00.000 Biotechnology Generating Revenue 000000 000000 00.0
Desktop Genetics 29-Aug-2013 Early Stage VC 00000 Biotechnology Generating Revenue 000000 000000 00.0
To view Darrin Disley’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Darrin Disley Exits (2)

Company Name Exit Date Exit Type Exit Size
Desktop Genetics 01-Jun-2018 Merger/Acquisition
00000000000 21-Jun-2017 000 00 00000000
To view Darrin Disley’s complete exits history, request access »

Darrin Disley Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Darrin Disley Team (1)

Name Title Deals Funds Boards Office
Darrin Disley Ph.D Angel Investor 00 0 Cambridge, United Kingdom
To view Darrin Disley’s complete team members history, request access »

Darrin Disley Co-Investors (3)

Name With Exits Lead Partner Series Industry
Jonathan Milner 1 0 Series chart Industry bar
Nikolaus Starzacher 0 0 Series chart Industry bar
Weslie Janeway 0 0 Series chart Industry bar
To view Darrin Disley’s complete co-investors history, request access »